Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manish Banerjee

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Chemical Biology & Drug Design|November 2, 2022
Identification of 5-(3-(methylsulfonyl)phenyl)-3-(4-(methylsulfonyl)phenyl)-3H-imidazo[4,5-b]pyridine as novel orally bioavailable and metabolically stable antimalarial compound for further explorationMrinalkanti Kundu, Aditi Dutta, Kuldeep K Roy, et al.
International Immunopharmacology|January 23, 2010
Pharmacological profile of AW-814141, a novel, potent, selective and orally active inhibitor of p38 MAP kinasePuneet Chopra, Onkar Kulkarni, Shashank Gupta, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Chemical Biology & Drug Design|November 2, 2022
Identification of 5-(3-(methylsulfonyl)phenyl)-3-(4-(methylsulfonyl)phenyl)-3H-imidazo[4,5-b]pyridine as novel orally bioavailable and metabolically stable antimalarial compound for further explorationMrinalkanti Kundu, Aditi Dutta, Kuldeep K Roy, et al.
International Immunopharmacology|January 23, 2010
Pharmacological profile of AW-814141, a novel, potent, selective and orally active inhibitor of p38 MAP kinasePuneet Chopra, Onkar Kulkarni, Shashank Gupta, et al.
Pageof 2